NasdaqCM - Nasdaq Real Time Price USD

Alaunos Therapeutics, Inc. (TCRT)

2.9000
-0.1100
(-3.65%)
As of 1:29:02 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
10
10
5
2,922
398
Operating Expense
4,822
4,822
28,498
38,160
77,207
Operating Income
-4,812
-4,812
-28,493
-35,238
-76,809
Net Non Operating Interest Income Expense
0
0
-1,921
-3,154
-1,189
Other Income Expense
133
133
-4,726
662
-753
Pretax Income
-4,679
-4,679
-35,140
-37,730
-78,751
Net Income Common Stockholders
-4,679
-4,679
-35,140
-37,730
-78,751
Diluted NI Available to Com Stockholders
-4,679
-4,679
-35,140
-37,730
-78,751
Basic EPS
-315.39
-2.92
-21.97
-25.50
-55.50
Diluted EPS
-315.39
-2.92
-21.97
-25.50
-55.50
Basic Average Shares
108.3630
1,601.2520
1,599.5320
1,447.5350
1,429.3270
Diluted Average Shares
108.3630
1,601.2520
1,599.5320
1,447.5350
1,429.3270
Total Operating Income as Reported
-4,812
-4,812
-34,267
-35,105
-77,549
Total Expenses
4,822
4,822
28,498
38,160
77,207
Net Income from Continuing & Discontinued Operation
-4,679
-4,679
-35,140
-37,730
-78,751
Normalized Income
-4,679
-4,679
-29,366
-37,863
-78,011
Interest Expense
0
0
1,921
3,154
1,189
Net Interest Income
0
0
-1,921
-3,154
-1,189
EBIT
-4,679
-4,679
-33,219
-34,576
-77,562
EBITDA
-4,677
-4,677
-30,904
-31,817
-74,965
Reconciled Depreciation
2
2
2,315
2,759
2,597
Net Income from Continuing Operation Net Minority Interest
-4,679
-4,679
-35,140
-37,730
-78,751
Total Unusual Items Excluding Goodwill
0
0
-5,774
133
-740
Total Unusual Items
0
0
-5,774
133
-740
Normalized EBITDA
-4,677
-4,677
-25,130
-31,950
-74,225
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 8/24/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PGEN Precigen, Inc.
1.3500
0.00%
 
OSRH OSR Holdings, Inc.
1.2600
-1.56%
 
NLSP NLS Pharmaceutics AG
1.6700
-1.76%
 
REVB Revelation Biosciences, Inc.
3.1700
+2.59%
 
APVO Aptevo Therapeutics Inc.
0.3399
-5.58%
 
QNRX Quoin Pharmaceuticals, Ltd.
6.20
-3.28%
 
CRMD CorMedix Inc.
12.04
+0.08%
 
CAMP CAMP4 THERAPEUTICS CORPORATION
2.0900
-2.34%
 
ENTO Entero Therapeutics, Inc.
0.4115
+3.21%
 
SANN.SW Santhera Pharmaceuticals Holding AG
13.18
-0.15%